v3.19.2
Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net Loss $ (8,710,833) $ (2,692,840) $ (10,414,441) $ (3,563,070)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation     11,122 2,533  
Stock based compensation     448,754  
Loss on debt extinguishment 50,000 75,000  
Amortization of debt discount     441,950 834,966  
Increase in notes payable and Series D-2 for defaults     1,545,174  
Impairment of software development cost     513,601  
Amortization of embedded derivative     933,411  
Loss on debt extinguishment     75,000  
Accretion of interest for note payable     1,854  
Loss on derivative liability and additional interest expense recorded on issuance     6,107,762 $ 1,637,572
Loss on exchange and issuance of preferred stock     666,626  
Excess fair market value of common stock over liabilities settled     196,711  
Accounts receivable     (12,833) (502)  
Prepaid expenses     (6,777) (460)  
Inventory     (3,236)  
Other current assets     107,294 (7,573)  
Security deposit     793 1,620  
Accounts payable and accrued liabilities     510,825 439,604  
Net Cash Used in Operating Activities     (355,429) (833,863)  
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchases of property and equipment     (18,457) (2,412)  
Cash received from acquisition     12,924 779  
Cash paid for acquisition     (79,937)  
Software development costs     (142,483) (133,240)  
Net Cash Used in Investing Activities     (227,953) (134,873)  
CASH FLOWS FROM FINANCING ACTIVITIES:          
Net proceeds (payments) to stockholders     62,326  
Repayment to stockholders     (16,931)  
Proceeds from convertible notes payable     427,740 418,824  
Proceeds from sale of preferred and common stock     135,136  
Costs of issuance of convertible notes     (33,824)  
Costs of issuance for cash     211,250  
Issuance on Series B Preferred stock     266,000  
Cash paid for capital raise     (6,000)  
Net Cash Provided by Financing Activities     562,876 901,645  
Effect of Exchange Rate Changes on Cash and Cash Equivalents     (11,419) 5,124  
Net decrease in cash and cash equivalents     (506) (61,967)  
Cash and cash equivalents, beginning of period     37,721 100,264 100,264
Cash and cash equivalents, end of period $ 25,796 $ 38,297 25,796 38,297 $ 37,721
Supplemental cash flow information          
Cash paid for interest      
Cash paid for taxes      
Non-cash investing and financing transactions:          
Conversion of convertible notes payable, accrued interest and derivative     969,114  
Discounts on convertible notes payable     452,258  
Conversion of preferred stock in common stock     758,352  
Reduction of APIC related to derivatives on preferred stock     850,695  
Conversions of Series B and D-2 preferred stock into common stock     539,157  
Exchange of common stock and preferred stock for difference series     1,145,938    
Issuance of Series D-2 for accounts payable     200,000    
Common stock to be issued in current period     92,646  
Common Stock issued in conjunction notes payable     86,602  
Original issue discount on convertible note payable     26,648  
Beneficial conversion feature for convertible notes payable     811,205  
Common stock for acquisition of EFG (see Note 3)     $ 80,000